Medical Marijuana, Inc. and Subsidiaries Announce July 2018 as the Largest Sales Month in Company History

SAN DIEGO, Aug. 2, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company and its subsidiaries Kannaway®HempMeds® MexicoPhyto Animal Health and Dixie Botanicals® have booked the largest-ever (unaudited) sales month in their history in July of 2018, as well as reached major milestones in business operations.

“We are excited to announce July of 2018 was the largest sales month in the history of our company,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We hope to further expand our operations in August and continue to reach milestones as an industry leader in the cannabis marketplace.”

Medical Marijuana, Inc. and its subsidiaries experienced many accomplishments in July 2018, including the release of a new cannabidiol (CBD) vape cartridge, the first of its kind for the company, to be distributed through subsidiary Dixie Botanicals®. The company also announced the release of a CBD hemp oil for pets called Dante’s Pure Hemp Oil through the company’s subsidiary Kannaway®.

“Achieving consecutive record-breaking months for over half the year is an exciting accomplishment for Medical Marijuana, Inc. and its subsidiaries,” said Medical Marijuana, Inc. COO Blake Schroeder. “This month was a milestone for the company with the release of two new products and we believe that 2018 will continue to be a year of firsts for us.”

Accomplishments also include six-time Olympic gold medalist Amy Van Dyken joining the Kannaway® Sports team as a spokesperson, as well as the company obtaining positive news coverage in several national and international news outlets including Forbes, The Street, Westword, Benzinga, Leafly and Entrepreneur.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]